STRS Ohio’s Nuvation Bio NUVB Stock Holding History

STRS Ohio’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.4K	Buy	4,300 +2,600	+153%	+$12.7K	﹤0.01%	2106
2026 Q1	$7.29K	Hold	1,700	–	–	﹤0.01%	2098
2025 Q4	$15.2K	Hold	1,700	–	–	﹤0.01%	2117
2025 Q3	$6.29K	Hold	1,700	–	–	﹤0.01%	2172
2025 Q2	$3.31K	Hold	1,700	–	–	﹤0.01%	2188
2025 Q1	$2.99K	Sell	1,700 -36,900	-96%	-$84K	﹤0.01%	1906
2024 Q4	$103K	Hold	38,600	–	–	﹤0.01%	1629
2024 Q3	$88.4K	Hold	38,600	–	–	﹤0.01%	1728
2024 Q2	$113K	Buy	38,600 +3,900	+11%	+$11.9K	﹤0.01%	1677
2024 Q1	$126K	Sell	34,700 -2,200	-6%	-$4.22K	﹤0.01%	1646
2023 Q4	$55K	Hold	36,900	–	–	﹤0.01%	1762
2023 Q3	$49K	Hold	36,900	–	–	﹤0.01%	1795
2023 Q2	$66K	Hold	36,900	–	–	﹤0.01%	1776
2023 Q1	$61K	Hold	36,900	–	–	﹤0.01%	1763
2022 Q4	$70K	Hold	36,900	–	–	﹤0.01%	1771
2022 Q3	$82K	Hold	36,900	–	–	﹤0.01%	1772
2022 Q2	$119K	Hold	36,900	–	–	﹤0.01%	1730
2022 Q1	$194K	Hold	36,900	–	–	﹤0.01%	1716
2021 Q4	$313K	Buy	36,900 +21,600	+141%	+$199K	﹤0.01%	1604
2021 Q3	$152K	Buy	15,300 +7,100	+87%	+$64.4K	﹤0.01%	1854
2021 Q2	$76K	Buy	+8,200	New	+$93.5K	﹤0.01%	2034

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

STRS Ohio's NUVB Position: Q2 2026 in Review

STRS Ohio increased its Nuvation Bio (NUVB) stake by 153% in Q2 2026, buying an estimated $12.7K and bringing the position to 4,300 shares worth $24.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2106.

STRS Ohio first reported a position in NUVB in Q2 2021 and has held it in 21 quarters since. The position peaked at $313K in Q4 2021. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

STRS Ohio held 4,300 shares of Nuvation Bio worth $24.4K as of Q2 2026.
STRS Ohio bought 2,600 Nuvation Bio shares in Q2 2026, an estimated $12.7K.
Nuvation Bio made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #2106 holding.
STRS Ohio first reported a position in Nuvation Bio in Q2 2021 and has held it in 21 quarters since.
STRS Ohio's Nuvation Bio position peaked at $313K in Q4 2021.
244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.